The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Emphysema Treatment-Global Market Insights and Sales Trends 2024
Synopsis
Chronic obstructive pulmonary disease (COPD) is kind of lung disease which happen due to chronic obstruction of lung airflow that interferes with normal breathing and is not fully reversible.
The global Emphysema Treatment market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Emphysema Treatment in various end use industries. The expanding demands from the Hospital, Clinics and Surgical center,, are propelling Emphysema Treatment market. Centrilobular emphysema, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Panlobular emphysema segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Emphysema Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Emphysema Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Emphysema Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Emphysema Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Emphysema Treatment covered in this report include Pulmonx, Bioxyne, Intrexon, Icure Pharmaceuticals, Kamada, Emphasys Medical, Pfizer, Olympus and BTG, etc.
The global Emphysema Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pulmonx
Bioxyne
Intrexon
Icure Pharmaceuticals
Kamada
Emphasys Medical
Pfizer
Olympus
BTG
PneumRx and Uptake Medical
Halozyme Therapeutics
Mariposa Health
Uptake Medical
Global Emphysema Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Emphysema Treatment market, Segment by Type:
Centrilobular emphysema
Panlobular emphysema
Global Emphysema Treatment market, by Application
Hospital
Clinics
Surgical center
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Emphysema Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Chronic obstructive pulmonary disease (COPD) is kind of lung disease which happen due to chronic obstruction of lung airflow that interferes with normal breathing and is not fully reversible.
The global Emphysema Treatment market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Emphysema Treatment in various end use industries. The expanding demands from the Hospital, Clinics and Surgical center,, are propelling Emphysema Treatment market. Centrilobular emphysema, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Panlobular emphysema segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Emphysema Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Emphysema Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Emphysema Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Emphysema Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Emphysema Treatment covered in this report include Pulmonx, Bioxyne, Intrexon, Icure Pharmaceuticals, Kamada, Emphasys Medical, Pfizer, Olympus and BTG, etc.
The global Emphysema Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pulmonx
Bioxyne
Intrexon
Icure Pharmaceuticals
Kamada
Emphasys Medical
Pfizer
Olympus
BTG
PneumRx and Uptake Medical
Halozyme Therapeutics
Mariposa Health
Uptake Medical
Global Emphysema Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Emphysema Treatment market, Segment by Type:
Centrilobular emphysema
Panlobular emphysema
Global Emphysema Treatment market, by Application
Hospital
Clinics
Surgical center
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Emphysema Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Emphysema Treatment
1.1 Emphysema Treatment Market Overview
1.1.1 Emphysema Treatment Product Scope
1.1.2 Emphysema Treatment Market Status and Outlook
1.2 Global Emphysema Treatment Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Emphysema Treatment Market Size by Region (2018-2029)
1.4 Global Emphysema Treatment Historic Market Size by Region (2018-2023)
1.5 Global Emphysema Treatment Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Emphysema Treatment Market Size (2018-2029)
1.6.1 North America Emphysema Treatment Market Size (2018-2029)
1.6.2 Europe Emphysema Treatment Market Size (2018-2029)
1.6.3 Asia-Pacific Emphysema Treatment Market Size (2018-2029)
1.6.4 Latin America Emphysema Treatment Market Size (2018-2029)
1.6.5 Middle East & Africa Emphysema Treatment Market Size (2018-2029)
2 Emphysema Treatment Market by Type
2.1 Introduction
2.1.1 Centrilobular emphysema
2.1.2 Panlobular emphysema
2.2 Global Emphysema Treatment Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Emphysema Treatment Historic Market Size by Type (2018-2023)
2.2.2 Global Emphysema Treatment Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Emphysema Treatment Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Emphysema Treatment Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Emphysema Treatment Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Emphysema Treatment Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Emphysema Treatment Revenue Breakdown by Type (2018-2029)
3 Emphysema Treatment Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Clinics
3.1.3 Surgical center
3.2 Global Emphysema Treatment Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Emphysema Treatment Historic Market Size by Application (2018-2023)
3.2.2 Global Emphysema Treatment Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Emphysema Treatment Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Emphysema Treatment Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Emphysema Treatment Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Emphysema Treatment Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Emphysema Treatment Revenue Breakdown by Application (2018-2029)
4 Emphysema Treatment Competition Analysis by Players
4.1 Global Emphysema Treatment Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Emphysema Treatment as of 2022)
4.3 Date of Key Players Enter into Emphysema Treatment Market
4.4 Global Top Players Emphysema Treatment Headquarters and Area Served
4.5 Key Players Emphysema Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Emphysema Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Pulmonx
5.1.1 Pulmonx Profile
5.1.2 Pulmonx Main Business
5.1.3 Pulmonx Emphysema Treatment Products, Services and Solutions
5.1.4 Pulmonx Emphysema Treatment Revenue (US$ Million) & (2018-2023)
5.1.5 Pulmonx Recent Developments
5.2 Bioxyne
5.2.1 Bioxyne Profile
5.2.2 Bioxyne Main Business
5.2.3 Bioxyne Emphysema Treatment Products, Services and Solutions
5.2.4 Bioxyne Emphysema Treatment Revenue (US$ Million) & (2018-2023)
5.2.5 Bioxyne Recent Developments
5.3 Intrexon
5.3.1 Intrexon Profile
5.3.2 Intrexon Main Business
5.3.3 Intrexon Emphysema Treatment Products, Services and Solutions
5.3.4 Intrexon Emphysema Treatment Revenue (US$ Million) & (2018-2023)
5.3.5 Icure Pharmaceuticals Recent Developments
5.4 Icure Pharmaceuticals
5.4.1 Icure Pharmaceuticals Profile
5.4.2 Icure Pharmaceuticals Main Business
5.4.3 Icure Pharmaceuticals Emphysema Treatment Products, Services and Solutions
5.4.4 Icure Pharmaceuticals Emphysema Treatment Revenue (US$ Million) & (2018-2023)
5.4.5 Icure Pharmaceuticals Recent Developments
5.5 Kamada
5.5.1 Kamada Profile
5.5.2 Kamada Main Business
5.5.3 Kamada Emphysema Treatment Products, Services and Solutions
5.5.4 Kamada Emphysema Treatment Revenue (US$ Million) & (2018-2023)
5.5.5 Kamada Recent Developments
5.6 Emphasys Medical
5.6.1 Emphasys Medical Profile
5.6.2 Emphasys Medical Main Business
5.6.3 Emphasys Medical Emphysema Treatment Products, Services and Solutions
5.6.4 Emphasys Medical Emphysema Treatment Revenue (US$ Million) & (2018-2023)
5.6.5 Emphasys Medical Recent Developments
5.7 Pfizer
5.7.1 Pfizer Profile
5.7.2 Pfizer Main Business
5.7.3 Pfizer Emphysema Treatment Products, Services and Solutions
5.7.4 Pfizer Emphysema Treatment Revenue (US$ Million) & (2018-2023)
5.7.5 Pfizer Recent Developments
5.8 Olympus
5.8.1 Olympus Profile
5.8.2 Olympus Main Business
5.8.3 Olympus Emphysema Treatment Products, Services and Solutions
5.8.4 Olympus Emphysema Treatment Revenue (US$ Million) & (2018-2023)
5.8.5 Olympus Recent Developments
5.9 BTG
5.9.1 BTG Profile
5.9.2 BTG Main Business
5.9.3 BTG Emphysema Treatment Products, Services and Solutions
5.9.4 BTG Emphysema Treatment Revenue (US$ Million) & (2018-2023)
5.9.5 BTG Recent Developments
5.10 PneumRx and Uptake Medical
5.10.1 PneumRx and Uptake Medical Profile
5.10.2 PneumRx and Uptake Medical Main Business
5.10.3 PneumRx and Uptake Medical Emphysema Treatment Products, Services and Solutions
5.10.4 PneumRx and Uptake Medical Emphysema Treatment Revenue (US$ Million) & (2018-2023)
5.10.5 PneumRx and Uptake Medical Recent Developments
5.11 Halozyme Therapeutics
5.11.1 Halozyme Therapeutics Profile
5.11.2 Halozyme Therapeutics Main Business
5.11.3 Halozyme Therapeutics Emphysema Treatment Products, Services and Solutions
5.11.4 Halozyme Therapeutics Emphysema Treatment Revenue (US$ Million) & (2018-2023)
5.11.5 Halozyme Therapeutics Recent Developments
5.12 Mariposa Health
5.12.1 Mariposa Health Profile
5.12.2 Mariposa Health Main Business
5.12.3 Mariposa Health Emphysema Treatment Products, Services and Solutions
5.12.4 Mariposa Health Emphysema Treatment Revenue (US$ Million) & (2018-2023)
5.12.5 Mariposa Health Recent Developments
5.13 Uptake Medical
5.13.1 Uptake Medical Profile
5.13.2 Uptake Medical Main Business
5.13.3 Uptake Medical Emphysema Treatment Products, Services and Solutions
5.13.4 Uptake Medical Emphysema Treatment Revenue (US$ Million) & (2018-2023)
5.13.5 Uptake Medical Recent Developments
6 North America
6.1 North America Emphysema Treatment Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Emphysema Treatment Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Emphysema Treatment Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Emphysema Treatment Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Emphysema Treatment Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Emphysema Treatment Market Dynamics
11.1 Emphysema Treatment Industry Trends
11.2 Emphysema Treatment Market Drivers
11.3 Emphysema Treatment Market Challenges
11.4 Emphysema Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
